StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · VANI·Healthcare

Vivani Medical, Inc. (VANI) Financial Ratios

Market Closed
$1.12
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
39
ST Score
39.3/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
Margins
Valuation
Liquidity & leverage
Efficiency
Cash flow
Dividends

VANI stock: frequently asked questions

What is VANI's ST Score?

Vivani Medical, Inc. (VANI) has an ST Score of 39.3 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is VANI a buy, hold, or sell?

Analysts rate VANI a Buy, with a price target of $4.00 (+257.1% vs the current price). Our ST Score grades it C (39.3/100). The ST Score is a data-driven signal, not a recommendation.

What are VANI's factor grades?

Valuation B+, Profitability D, Financial Strength D, Momentum B-, Growth D, Forecast A.

What is VANI's valuation grade?

Vivani Medical, Inc. (VANI) earns a valuation grade of B+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is VANI's growth grade?

Vivani Medical, Inc. (VANI) earns a growth grade of D, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is VANI's profitability grade?

Vivani Medical, Inc. (VANI) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is VANI's financial strength grade?

Vivani Medical, Inc. (VANI) earns a financial strength grade of D, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for VANI?

The average analyst price target for Vivani Medical, Inc. (VANI) is $4.00 from 2 analysts, which is +257.1% versus the recent price of $1.12.

What is VANI's Piotroski score?

Vivani Medical, Inc. (VANI) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.